CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Cullinan Therapeutics, Inc. (CGEM) on Tuesday reported a loss of $49.4 million in its third quarter. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 74 cents. The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks...